Monitoring the CD4/CD8 ratio: a promising indicator of disease progression in HIV-infected individuals?

about

Monitoring the CD4/CD8 ratio: a promising indicator of disease progression in HIV-infected individuals?

Item

http://www.wikidata.org/entity/Q59118545

description

article

@en

im Jahr 2015 veröffentlichter wissenschaftlicher Artikel

@de

wetenschappelijk artikel

@nl

наукова стаття, опублікована в січні 2015

@uk

name

Monitoring the CD4/CD8 ratio: ...... n in HIV-infected individuals?

@en

Monitoring the CD4/CD8 ratio: ...... n in HIV-infected individuals?

@nl

type

Item

label

Monitoring the CD4/CD8 ratio: ...... n in HIV-infected individuals?

@en

Monitoring the CD4/CD8 ratio: ...... n in HIV-infected individuals?

@nl

prefLabel

Monitoring the CD4/CD8 ratio: ...... n in HIV-infected individuals?

@en

Monitoring the CD4/CD8 ratio: ...... n in HIV-infected individuals?

@nl

P1476

Monitoring the CD4/CD8 ratio: ...... n in HIV-infected individuals?

@en

P2093

Santiago Moreno

http://www.w3.org/2001/XMLSchema#string

Sergio Serrano-Villar

http://www.w3.org/2001/XMLSchema#string

P2860

CD8 T cell persistence in treated HIV infection

The CD4:CD8 ratio is associated with markers of age-associated disease in virally suppressed HIV-infected patients with immunological recovery

Systemic effects of inflammation on health during chronic HIV infection

Clinical, immunological and treatment-related factors associated with normalised CD4+/CD8+ T-cell ratio: effect of naïve and memory T-cell subsets

HIV-infected individuals with low CD4/CD8 ratio despite effective antiretroviral therapy exhibit altered T cell subsets, heightened CD8+ T cell activation, and increased risk of non-AIDS morbidity and mortality.

Factors associated with preclinical disability and frailty among HIV-infected and HIV-uninfected women in the era of cART

HIV infection, inflammation, immunosenescence, and aging.

Predictors of CD4:CD8 ratio normalization and its effect on health outcomes in the era of combination antiretroviral therapy.

Impact of HIV on CD8+ T cell CD57 expression is distinct from that of CMV and aging.

Delay in cART initiation results in persistent immune dysregulation and poor recovery of T-cell phenotype despite a decade of successful HIV suppression.

P304

1-4

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/FVL.14.85

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Talía Sainz

P577

2015-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime